Search results
All bacterial and viral vaccines licensed for intranasal administration in cats are attenuated live, as are a number of parenteral vaccines. Recombinant vaccines are created through manipulation of the deoxyribonucleic acid (DNA) of a pathogen in the laboratory, with reduction in pathogen virulence.
Provides faster protection against respiratory disease than SQ which is relevant in high-risk populations and with kittens. *Consider at 6 months of age to decrease the potential window of susceptibility if the kitten had MDA at the last kitten booster.
A combination feline parvovirus (FPV), FHV-1, and FCV vaccine is recommended for all cats, beginning as early as 6 to 8 weeks of age, regardless of vaccine type. Kittens should receive an additional dose every 3 to 4 weeks until 16 to 20 weeks of age.
27 cze 2013 · Recommended topical treatment is repeated body rinse with an enilconazole solution or miconazole with or without chlorhexidine. In catteries/shelters medication must be accompanied by intensive decontamination of the environment. Vaccination:
Recommended topical treatment is repeated body rinse with an enilconazole solution or miconazole with or without chlorhexidine. In catteries/shelters medication must be accompanied by intensive decontamination of the environment.
Percutaneous core biopsies (e.g., Tru-Cut) are the best technique for achieving a safe and accurate diagnosis and can easily be performed with local anaesthetic alone or with sedation in nervous patients. Tru-Cut biopsies will reliably differentiate benign from malignant disease and in most cases will also give a good indication of grade.
1 sty 2011 · Objective. We sought to define major T-cell epitopes of Fel d 1 for peptide immunotherapy, generate a peptide vaccine, and evaluate its safety and tolerability in subjects with cat allergy. Methods. We determined the binding affinities of Fel d 1 peptides for 10 commonly expressed HLA-DR molecules.
